HIV-1 treatment failure among population taking Antiretroviral Therapy in Ethiopia

Yimam Getaneh1*, Atsbeha G Egziabhier2, Kidist Zealiyas2, Rahel Tilahun2, Mulu Girma2, Gebremedihin G/ Michael1, Tekalign Deressa1, Ebba Abate1, Desta Kassa1, Yibeltal Assefa2 1Ethiopian Public Health Institute, HIV and TB Research Directorate, Addis Ababa, Ethiopia 2School of Public Health, University of Queensland, Australia *Correspondence should be addressed to Yimam Getaneh; yimamgetaneh@gmail.com Received date: September 19, 2019, Accepted date: October 05, 2019 Copyright: © 2019 Getaneh Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

[1]  P. Hill,et al.  Towards achieving the fast-track targets and ending the epidemic of HIV/AIDS in Ethiopia: Successes and challenges. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  Araya Gebreyesus Wasihun,et al.  Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia , 2018, PloS one.

[3]  M. Ayalew.  Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review. , 2017 .

[4]  H. Gesesew,et al.  Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015 , 2017, PloS one.

[5]  M. Ayalew,et al.  First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia , 2016, HIV/AIDS.

[6]  G. Shakya,et al.  Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal , 2016, BioMed research international.

[7]  A. Yalew,et al.  Magnitude and Predictors of Anti-Retroviral Treatment (ART) Failure in Private Health Facilities in Addis Ababa, Ethiopia , 2015, PloS one.

[8]  B. M. Zeleke,et al.  Predictors of CD4 Count Changes after Initiation of Antiretroviral Treatment in University of Gondar Hospital, Gondar in Ethiopia , 2015 .

[9]  D. Wohl,et al.  Antiretroviral therapy: when to start. , 2014, Infectious disease clinics of North America.

[10]  L. Lynen,et al.  Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013 , 2014, Globalization and Health.

[11]  T. F. Rinke de Wit,et al.  HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study , 2014, AIDS Research and Therapy.

[12]  W. Blattner,et al.  Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria , 2013, BMC Infectious Diseases.

[13]  Gundo Weiler,et al.  Global Update on HIV Treatment 2013: Results, Impact and Opportunities , 2013 .

[14]  T. Quinn,et al.  Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda , 2012, BMC Infectious Diseases.

[15]  M. Arnedo,et al.  Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, Kenya , 2012, PloS one.

[16]  C. Beyrer,et al.  HIV/AIDS Prevention, Treatment and Care: Present Status, Future Needs and Some Possible Solutions , 2008 .